Financials BOIRON

Equities

BOI

FR0000061129

Pharmaceuticals

Market Closed - Euronext Paris 11:35:07 2024-04-26 am EDT 5-day change 1st Jan Change
33.75 EUR -1.60% Intraday chart for BOIRON -0.15% -16.09%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 859.8 637.4 724 626.3 880.6 586 586 -
Enterprise Value (EV) 1 643 435 501.7 404.4 651.8 698.3 465 315.1
P/E ratio 15.2 x 15.7 x 27.6 x 21.9 x 19.7 x 14.2 x 15.6 x 12.7 x
Yield 2.96% 2.88% 2.3% 2.66% 2.17% 3.01% 2.9% 3.33%
Capitalization / Revenue 1.42 x 1.14 x 1.41 x 1.38 x 1.65 x 1.42 x 1.15 x 1.09 x
EV / Revenue 1.06 x 0.78 x 0.98 x 0.89 x 1.22 x 1.42 x 0.92 x 0.59 x
EV / EBITDA 4.58 x 4.22 x 4.76 x 6.67 x 8.58 x 3.82 x 5.81 x 3.5 x
EV / FCF 17.6 x 32.6 x 10.5 x 18.1 x 13.5 x 4.68 x 9.45 x 5.7 x
FCF Yield 5.69% 3.06% 9.48% 5.52% 7.43% 21.4% 10.6% 17.5%
Price to Book 1.76 x 1.26 x 1.42 x 1.18 x 1.58 x 1.02 x 1.35 x 1.07 x
Nbr of stocks (in thousands) 17,566 17,511 17,508 17,519 17,368 17,362 17,362 -
Reference price 2 48.95 36.40 41.35 35.75 50.70 33.75 33.75 33.75
Announcement Date 3/13/19 3/11/20 3/10/21 3/10/22 3/21/23 4/2/24 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 604.2 557.1 513.6 455.2 534.2 493.2 508 537
EBITDA 1 140.4 103 105.5 60.61 75.97 79.95 80 90.05
EBIT 1 106 66.92 38.18 46.84 63.45 42.29 46.6 61.55
Operating Margin 17.55% 12.01% 7.44% 10.29% 11.88% 8.57% 9.17% 11.46%
Earnings before Tax (EBT) 104 64.38 37.22 46.11 59.2 - - -
Net income 1 57.46 40.63 26.21 28.56 44.67 35.83 37.7 46.3
Net margin 9.51% 7.29% 5.1% 6.27% 8.36% 7.26% 7.42% 8.62%
EPS 2 3.230 2.320 1.500 1.630 2.570 2.375 2.170 2.655
Free Cash Flow 1 36.57 13.33 47.57 22.33 48.45 65.3 49.2 55.25
FCF margin 6.05% 2.39% 9.26% 4.91% 9.07% 12.61% 9.69% 10.29%
FCF Conversion (EBITDA) 26.05% 12.94% 45.09% 36.84% 63.78% 81.68% 61.5% 61.35%
FCF Conversion (Net income) 63.64% 32.81% 181.49% 78.18% 108.46% 157.54% 130.5% 119.33%
Dividend per Share 2 1.450 1.050 0.9500 0.9500 1.100 1.015 0.9800 1.125
Announcement Date 3/13/19 3/11/20 3/10/21 3/10/22 3/21/23 4/2/24 - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2020 S1 2021 Q2 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2
Net sales 1 256.7 253.6 98.76 189.9 117.8 145.8 111 256.8 128.4 149.1 132.3 107.6 239.9 121.1 160 -
EBITDA - - - - - - - - - - - - - - - -
EBIT 16.03 1.496 - -11.04 - - - 19.99 - - - - - - - 38.9
Operating Margin 6.24% 0.59% - -5.81% - - - 7.79% - - - - - - - -
Earnings before Tax (EBT) - 1.448 - - - - - - - - - - - - - -
Net income - -0.975 - -9.514 - - - - - - - - - - - -
Net margin - -0.38% - -5.01% - - - - - - - - - - - -
EPS - - - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - - -
Announcement Date 7/18/19 9/9/20 9/9/21 9/9/21 12/10/21 6/21/22 9/21/22 - 10/21/22 3/21/23 4/28/23 10/2/23 - 10/20/23 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - - -
Net Cash position 1 217 202 222 222 229 280 121 271
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 36.6 13.3 47.6 22.3 48.5 65.3 49.2 55.3
ROE (net income / shareholders' equity) 11.5% 8.2% 5.17% 5.49% 8.2% 7.25% 8.9% 8.55%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 27.70 28.90 29.10 30.40 32.10 33.20 24.90 31.40
Cash Flow per Share 2 4.740 2.900 3.900 1.900 3.380 3.960 4.480 4.860
Capex 1 39.4 37.5 20.7 11 10.2 21.7 20.2 22.5
Capex / Sales 6.52% 6.74% 4.03% 2.41% 1.92% 4.19% 3.98% 4.19%
Announcement Date 3/13/19 3/11/20 3/10/21 3/10/22 3/21/23 4/2/24 - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
33.75 EUR
Average target price
39.6 EUR
Spread / Average Target
+17.33%
Consensus

Quarterly revenue - Rate of surprise